Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Brentuximab Vedotin 1.8 / Nivolumab 3, Hodgkin Lymphoma, cycle 1

Protocol-ID: 1903 V1.0 (Mini), BRNT1.8/NIVO3, Hodgkin, C1

Indication(s)

  • Hodgkin Lymphoma; ICD-10 C81.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 17.12.2021